基于蛋白质的组织粘合剂减少了外周血管手术中血液静止的时间
Nicola Troisi1, Michele Marconi1, Stefano Michelagnoli2
1Vascular Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Firenze, Italy.
Vascular
|May 31, 2024
概括
基于蛋白质的组织粘合剂Bioglue®显著减少了血液静止的时间,并在外周血管手术中减少了针的需要. 然而,它没有影响整体出血率,因此需要进一步调查.
科学领域:
- 血管外科 血管外科
- 生物材料是一种生物材料.
- 外科手术静血 静血是什么
背景情况:
- 周围血管外科手术涉及对四肢动脉和静脉的手术.
- 实现快速有效的血液静止对于患者的治疗结果至关重要.
- 基于蛋白质的组织粘合剂为手术血液控制提供了潜在的辅助.
研究的目的:
- 评估基于蛋白质的组织粘合剂Bioglue®在缩短血液静止时间方面的有效性.
- 为了比较接受Bioglue®和对照组患者之间的术后参数.
- 评估Bioglue®对需要附加和医院内出血的影响.
主要方法:
- 一项随机对照试验,涉及100名在四个中心接受开放外周血管手术的患者.
- 患者被分配到Bioglue®组 (生物组) 或对照组 (无生物组).
- 测量的主要结果包括血液静止的时间,辅助数和医院内出血事件,使用t测试和Gehan-Breslow-Wilcoxon测试进行分析.
主要成果:
- 与对照组 (9.6 分钟) 相比,Bioglue® 组 (4.4 分钟) 的静血时间明显更快 (p < 0.001).
- 在Bioglue®组 (16%) 与对照组 (50%) (p < 0.001) 中,对辅助的要求明显较低.
- 两组医院内出血总比率没有显著差异 (18%在生物组与14%在无生物组; p = 0.39).
结论:
- 生物有效地缩短了实现血液静止的时间,并减少了在外周血管外科手术中需要额外的需要.
- 使用Bioglue®并没有改变需要干预的术后出血的总体发病率.
- 建议进行更大规模的研究来证实这些发现,并进一步阐明Bioglue®在血管程序中的作用.
更多相关视频
05:30Author Spotlight: Exploring the Potential of Fat-Derived Stromal Vascular Fraction for Wound Healing
Published on: November 17, 2023
562
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
4.0K
相关概念视频
01:05Introduction to Hemostasis
7.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.3K
01:16Vascular Spasm
1.4K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.4K
01:22Formation of the Platelet Plug
5.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.8K
01:16Clot Retraction and Fibrinolysis
5.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.5K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675